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Background: This case-report characterized the respiratory, cardiovascular, and
nutritional/gastrointestinal (GI) responses of a trained individual to a novel ultra-
endurance exercise challenge.
Case Presentation: A male athlete (age 45 years; V˙O2max 54.0 mL·kg−1·min−1)
summited 100 mountains on foot in 25 consecutive days (all elevations >600 m).
Measures: Laboratory measures of pulmonary function (spirometry, whole-body
plethysmography, and single-breath rebreathe), respiratory muscle function (maximum
static mouth-pressures), and cardiovascular structure and function (echocardiography,
electrocardiography, large vessel ultrasound, and flow-mediated dilatation) were made
at baseline and 48 h post-challenge. Dietary intake (four-day food diary), self-reported GI
symptoms and plasma endotoxin concentrations were assessed at baseline, pre/post
mid-point, pre/post end-point, and 48 h post-challenge.
Results: The challenge was completed in a total exercise time of 142 h
(5.3 ± 2.8 h·d−1), with a distance of 1141 km (42.3 ± 43.9 km·d−1), and energy
expenditure of 80460 kcal (2980 ± 1451 kcal·d−1). Relative to baseline, there
were post-challenge decreases in pulmonary capacities and expiratory flows (≤34%),
maximum expiratory mouth-pressure (19%), and maximum voluntary ventilation (29%).
Heart rate variability deteriorated, manifesting as a 48% decrease in the root mean
square of successive differences and a 70% increase in the low-frequency/high-
frequency ratio. Pre- to post-challenge endotoxin concentrations were elevated by 60%,
with a maximum increase of 130% after a given stage, congruent with an increased
frequency and severity of GI symptoms.
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Conclusion: The challenge resulted in pulmonary and autonomic dysfunction,
endotoxaemia, and GI distress. The findings extend our understanding of the limits of
physiological function and may inform medical best-practice for personnel supporting
ultra-endurance events.
Keywords: cardiovascular, nutrition, respiratory, ultra-endurance, ultra-marathon
BACKGROUND
Ultra-endurance exercise (>6 h duration) induces substantial
physiological demands on multiple body systems (Zaryski
and Smith, 2005). For example, single-stage ultra-marathon
can provoke a pre- to post-race decrease in magnetically
evoked mouth twitch-pressure, indicative of inspiratory muscle
fatigue (Wuthrich et al., 2015), and post-race reductions
in pulmonary function (Vernillo et al., 2015). Studies of
the cardiovascular response to Ironman triathlon and ultra-
marathon have shown acute (transient) reductions in right
ventricular ejection fraction (O’Keefe et al., 2012), with long-
term participation causing pathological changes in cardiac
structure, function, and electrical activity (for review, see George
et al., 2012). Gastrointestinal (GI) distress is a commonly
cited reason for ultra-marathon non-completion (de Oliveira
and Burini, 2014) and is associated with the acute release of
intestinal endotoxins (Jeukendrup et al., 2000), the repeated
exposure to which may lead to a low-grade inflammatory state
(Mach and Fuster-Botella, 2017). Collectively, the literature
indicates that ultra-endurance exercise is sufficient to cause
acute physiological dysfunction and chronic maladaptations of
the respiratory, cardiovascular, digestive, and immune systems
(Knechtle and Nikolaidis, 2018).
Participation in ultra-endurance events has steadily
increased over the last 30 years (Hoffman et al., 2010).
Despite the available research, no study has investigated the
integrative physiological consequences of ultra-endurance
exercise repeated on consecutive days. Data to this
effect may inform best practice for personnel overseeing
the events; i.e., medics, race directors, and volunteers.
Accordingly, we implemented a series of laboratory-
and field-assessments with the aim of characterizing the
respiratory, cardiovascular, and nutritional/GI responses to
a 25-day ultra-endurance exercise challenge contested by
an experienced athlete. The unique challenge also offered
an excellent opportunity to study the limits of human
physiological function.
CASE PRESENTATION
Participant
The participant (one of four contesting the challenge) was
a highly-trained male endurance athlete (age 44.8 years;
mass 81.7 kg; stature 1.71 m). He had ∼20 years of
experience contesting running and cycling events, had
been preparing for the challenge for ∼18 months by
competing in marathon and ultra-marathon running and
walking events, and had a single-stage marathon season’s
best of 3 h 20 min. Overarching ethical approval for
the study was granted by the Sheffield Hallam University
Research Ethics Committee, in collaboration with University
College London, Anglia Ruskin University, and Brunel
University London. Written, informed consent was provided
after the participant received medical clearance from his
General Practitioner.
The Challenge
The 100-Peaks Challenge was novel in that it had not been
attempted previously. The task was to summit 100 mountains
(all elevations >600 m) throughout England (n = 45), Scotland
(n = 45) and Wales (n = 10) in 25 consecutive days. All
peaks were summited on foot, and the athletes cycled among
the geographical regions. The team slept each night at a pre-
determined base-camp which had been established at each of
the challenge locations, and which comprised basic sleeping
and cooking facilities. The team carried backpacks containing
essential equipment and were supported by a crew of volunteers
who provided food and basic medical assistance.
Study Overview
Approximately 1 month prior to the start of the challenge,
the participant completed an incremental exercise test on
a motorized treadmill (h/p Cosmos Saturn, h/p Cosmos
Sports & Medical GmbH, Traunstein, Germany) for the
determination of peak cardiorespiratory responses. On a
separate day, indices of respiratory, cardiovascular, and
nutritional/GI function were assessed at resting baseline,
and repeated at the first opportunity (48 h) after the
challenge. Additional measures of nutritional/GI function
were made pre- and post-exercise at the challenge mid- and
end-points (see below).
Respiratory Measures
Pulmonary function was assessed using a fully integrated system
(Masterscreen Body, CareFusion, Hampshire, United Kingdom).
First, airway resistance (sRaweff, Raweff) was measured using the
interrupter technique. Next, pulmonary volumes and capacities
(TLC, total lung capacity; RV, residual volume; FRC, functional
residual capacity; and IC, inspiratory capacity) were assessed
using body plethysmography. Dynamic volumes and flows
(FVC, forced vital capacity; FEV1, forced expiratory volume
in 1 s; and PEF, peak expiratory flow) were then assessed via
spirometry. Alveolar diffusing capacity (DLCO) was estimated
using the single-breath CO-rebreathe method. To quantify
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respiratory muscle strength, maximum static inspiratory mouth-
pressure (MIP, from RV) and maximum static expiratory
mouth-pressure (MEP, from TLC) were recorded using a
handheld device (MicroRPM, CareFusion). Immediately after the
mouth-pressure maneuvers, the participant rated his perceived
intensity of respiratory muscle soreness by marking a line on
a 100 mm visual analog scale (VAS) and indicated the location
of soreness by shading areas on a body diagram (Mathur
et al., 2010). Finally, the maximum voluntary ventilation in
12 s (MVV12) was assessed as an index of dynamic ventilatory
capacity. All procedures followed recommended guidelines
(Green et al., 2002; Macintyre et al., 2005; Miller et al., 2005;
Wanger et al., 2005).
Cardiovascular Measures
Cardiac
Cardiac morphology was assessed with an echocardiograph fitted
with a 2–4 MHz phased array transducer (IE33, Philips, NV,
United States) while the participant adopted a left-sided half-
lateral decubitus position. A 12-lead electrocardiogram (ECG)
running on dedicated software (CardioSoft, GE Healthcare,
Milwaukee, WI, United States) was used to record cardiac
rhythms and heart rate variability (HRV). The latter was
displayed as root mean square of successive differences (RMSSD)
and low/high frequency ratios (LF/HF). Cardiac assessments
were made according to recommended standards (Parati et al.,
2014; Oxborough et al., 2018).
Vascular
Blood pressure (systolic, diastolic, and mean arterial) was
assessed using a digital automated sphygmomanometer (Omron
M6, Omron Healthcare, Netherlands). Carotid intima-media
thickness (cIMT) was measured in the common carotid
artery using B-mode ultrasound (Zonare Z. OneUltra, Zonare
Medical Systems, United States) connected to dedicated software
(Carotid Analyzer, Medical Imaging Applications, Coralville,
IA., United States). To calculate carotid-femoral pulse-wave
velocity (PWV), arterial stiffness was measured using applanation
tonometry (SphygmoCor Vx, AtCor Medical, NSW, Australia).
Macrovascular and microvascular endothelial function were
measured via flow-mediated dilatation (FMD; IE33, Philips, NV,
United States) and endothelial peripheral arterial tonometry
(EndoPAT, Itamar Medical, Israel), respectively.
Nutritional/GI Measures
Dietary Intake and GI Distress
Following guidance on diary collation, meal content, portion
size and fluid intake, a 4-day dietary intake was recorded
at baseline, mid-point (day 13), and end-point (day 25).
Nutritional analyses were performed using dedicated software
(Nutritics Professional, Nutritics Ltd., Co., Dublin, Ireland).
The participant wore a telemetric device (Fenix 3, Garmin,
Hampshire, United Kingdom) which collected heart rate data
allowing for the estimation of energy expenditure (Keytel et al.,
2005). Concurrent with each dietary assessment, GI symptoms
(GIS) were graded for frequency using a category scale (0 = none;
1 = mild/occasional; 3 = moderate; 5 = frequent) and severity
using a 100 mm VAS. A nominal GI index (a.u, arbitrary units)
was calculated for each reported symptom using the product of
frequency and severity.
Endotoxin Concentration
At baseline, pre- and post-exercise at the mid-point (day
13), pre- and post-exercise at the end-point (day 25), and
48 h after the challenge, venous whole-blood was collected
at rest into duplicate 4 mL vacutainers (K3EDTA, Greiner
Bio-One GmbH, Kremsmunster, Austria). Samples were
centrifuged for 10 min at 3000 rpm, with aliquoted plasma
frozen at −80◦C. Endotoxin concentration was quantified
using an end-point chromogenic assay method (Pierce R©
LAL Chromogenic Endotoxin Quantitation Kit, Thermo
Fisher Scientific, Massachusetts, United States) using methods
previously described (Roberts et al., 2016).
RESULTS
Participant
Baseline assessments revealed no respiratory, cardiovascular, or
blood-borne abnormalities. The maximal incremental exercise
test elicited a V˙O2max of 4.41 L·min−1 (54.0 mL·kg−1·min−1)
and a V˙Emax of 152 L·min−1 (106% MVV12). The challenge
required a total energy expenditure of 80460 kcal (2980 ± 1451
kcal·d−1). The participant completed the 100-Peaks Challenge in
a total exercise time of 142 h [on foot = 106 h (75%); cycling = 36 h
(25%)], and a mean exercise time of 5.3 ± 2.8 h·d−1. The
total distance covered was 1141 km [on foot = 324 km
(28%); cycling = 817 km (72%)], with a mean distance of
42.3 ± 43.9 km·d−1. The challenge required a total ascent of
33804 m [on foot = 27038 m (80%); cycling = 6765 m (20%)],
and a mean ascent of 1252± 807 m·d−1.
Respiratory Responses
Pulmonary and respiratory muscle function at baseline and
48 h after the challenge are summarized in Table 1. Pre- and
post-challenge static lung volumes and capacities are shown
in Figure 1. Baseline pulmonary function generally exceeded
predicted values but remained within normal limits. At 48 h
post-challenge, there were notable reductions (range 8–34%)
in FVC, FEV1, TLC, RV, IC, PEF, MVV12, and metrics of
airway resistance. The ratio of FEV1/FVC was increased slightly
pre- to post-challenge (5%), with larger increases in DLCO
(15%). Maximum static inspiratory pressure was relatively well
preserved pre- to post-challenge. By contrast, there was a
substantial reduction in maximum static expiratory pressure
(-19%). There were no notable changes in perceptions of
respiratory muscle soreness. At day 14 of 25, the participant
developed symptoms of upper-respiratory tract infection (URTI)
including sore throat and mucous production that remained until
the post-challenge assessment.
Cardiovascular Responses
Cardiovascular structure and function at baseline and 48 h
after the challenge are summarized in Table 2. Heart rate
variability assessed via RMSSD decreased by 48% (23 vs.
12 ms) and the LF/HF ratio increased by 70% (1.7 vs. 2.8).
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TABLE 1 | Pulmonary and respiratory muscle function at baseline and 48 h
after the challenge.
Pre-challenge Post-challenge
Absolute % Pred Absolute % pred % change
FVC (L) 4.43 102 3.88 90 −12
FEV1 (L) 3.72 104 3.39 96 −9
FEV1/FVC 0.84 106 0.88 111 +5
TLC (L) 6.58 100 5.62 86 −15
RV (L) 1.85 91 1.70 84 −8
ERV (L) 2.06 159 2.17 167 +5
FRCpleth (L) 3.91 118 3.87 117 −1
IVC (L) 4.73 106 3.92 88 −17
IC (L) 2.67 84 1.75 55 −34
PEF (L/s) 11.42 131 8.21 94 −28
MVV12 (L/min) 143 110 102 79 −29
sRaweff (kPa/s/L) 0.38 33 0.32 27 −16
Raweff (kPa/s) 0.09 29 0.08 25 −11
DL,CO (mmol/min/kPa) 10.8 108 12.4 125 +15
MIP (cmH2O) −114 100 −122 107 +7
MEP (cmH2O) 233 170 188 140 −19
FVC, forced vital capacity; FEV1, forced expiratory volume in one second; TLC,
total lung capacity; RV, residual volume; ERV, expiratory reserve volume; FRC,
functional residual capacity; IVC, inspiratory vital capacity; IC, inspiratory capacity;
PEF, peak expiratory flow; MVV12, maximum voluntary ventilation in 12 s; sRaweff,
specific effective airway resistance; Raweff, effective airway resistance; DL,CO,
carbon monoxide diffusing capacity of the lung (uncorrected for Hb); MIP, maximum
inspiratory pressure; MEP, maximum expiratory pressure.
At the post-challenge assessment, the E/A wave ratio had
increased by 36% (1.1 vs. 1.5). The participant exhibited
no noteworthy changes in any other index of cardiovascular
structure or function.
FIGURE 1 | Static lung volumes and capacities at baseline and 48 h after the
challenge. Note the substantial post-challenge reduction in TLC, attributable
primarily to a fall in IC. TLC, total lung capacity; IC, inspiratory capacity; ERV,
expiratory reserve volume; RV, residual volume; FRC, functional
residual capacity.
Nutritional Intake and GI Responses
Nutritional intake and GI responses are summarized in Table 3.
As expected, energy intake increased substantially throughout
the challenge via progressive increases in carbohydrate ingestion
(partly from refined sugars) and dietary fat. Despite the increase
in energy intake, body mass was maintained pre- to post-
challenge (81.7 vs. 81.4 kg). At the challenge end-point (day 25)
GIS had increased from 35 to 127 a.u., reflecting both increased
symptom frequency and severity. Endotoxin concentration was
considered normal at resting baseline (10.9 pg·ml−1; expected
range 3–10 pg·ml−1), increased modestly by the mid-point
(17.1 pg·ml−1), and remained above baseline at 48 h post-
challenge (17.6 pg·ml−1). There were transient increases in
endotoxin concentration after a given bout of exercise when
assessed at the challenge mid- and end-points (25.5 and
24.3 pg·ml−1, respectively).
DISCUSSION
This is the first report of the integrative physiological response of
a trained athlete to a novel ultra-endurance stage-race. At 48 h
post-challenge, the principal observations were: (i) reductions in
several metrics of pulmonary function and a substantial pre- to
post-challenge decrease in maximum expiratory pressure; (ii) a
substantial reduction in HRV; and (iii) large increases in calorie
TABLE 2 | Cardiovascular structure and function at baseline and 48 h after the
challenge.
Pre-challenge Post-challenge % change
Cardiac
Fractional shortening (%) 29 26 −10
LA diameter (cm) 4.5 4.3 −4
E/A wave ratio 1.1 1.5 +36
TAPSE (cm) 3.4 3.3 −3
Autonomic
HR (b·min−1) 52 50 −4
HRV
RMSSD (ms) 23 12 −48
LF/HF 1.66 2.82 +70
Vascular
cIMT (mm) 0.48 0.47 −2
PWV (m/s) 7.0 7.7 +10
FMD (%) 3.5 3.2 −9
RHI 0.44 0.52 +18
Blood Pressure
SBP (mmHg) 123 121 −2
DBP (mmHg) 73 68 −7
MAP (mmHg) 90 85 −6
LA, left atrium; E/A wave ratio, the ratio of early diastolic peak flow velocity (E)
to late diastolic peak flow velocity (A); TAPSE, tricuspid annular plane systolic
excursion; HR, heart rate; HRV, heart rate variability; RMSSD, root mean square of
successive differences; LF/HF, low frequency/high frequency; cIMT, carotid intima-
media thickness; PWV, pulse wave velocity; FMD, flow mediated dilatation; RHI,
reactive hyperaemia index; SBP, systolic blood pressure; DBP, diastolic blood
pressure; MAP, mean arterial pressure.
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intake (congruent with metabolic demands), GIS prevalence, and
endotoxin concentration. Collectively, these observations suggest
that 25 days of endurance exercise has the potential to induce
long-lasting respiratory, cardiovascular, and GI dysfunction.
Respiratory Responses
The post-challenge respiratory assessments revealed a restrictive
pattern characterized by a fall in attainable lung volumes
and capacities (see Table 1). Although post-challenge FVC
and FEV1 were both reduced (9–12%), the FEV1/FVC ratio
was elevated (5%), and exceeded normal values, suggesting
an elevated expiratory flow relative to lung volume. That RV
and ERV were relatively well preserved while IC decreased
(34%) indicates that the decrease in FVC was primarily the
result of an inability to fully expand the lung on inspiration
(Figure 1). Moreover, the variability of IC was similar pre-
vs. post-challenge (data not shown), thereby discounting
a diminished inspiratory effort. Moreover, there was no
evidence of inspiratory muscle fatigue (MIP −114 vs. −122
cmH2O). We propose, therefore, that the restricted lung
expansion was attributable to reduced lung compliance
and/or increased ribcage stiffness, the causes of which
require further study.
We also observed a substantial (19%) pre- to post-
challenge reduction in maximum expiratory pressure (MEP),
the magnitude of which was similar to that noted following
TABLE 3 | Nutritional intake (4-day average) and GI responses at baseline,
mid-point (day 13), and end-point (day 25).
Pre-challenge Mid-point End-point % change∗
Body mass (kg) 81.7 81.7 81.4 <1
Energy (kcal/d) 2008 3814 4558 +127
Energy (kcal/kg/d) 24.6 46.7 56.0 +127
Carbohydrate (g/d) 156 446 581 +272
Carbohydrate (g/kg/d) 1.9 5.5 7.1 +274
Sugar (g/d) 66 160 198 +200
Sugar (g/kg/d) 0.8 2.0 2.4 +200
Protein (g/d) 157 179 185 +18
Protein (g/kg/d) 1.9 2.2 2.3 +21
Fat (g/d) 84 146 166 +98
Fat (g/kg/d) 1.0 1.8 2.0 +100
Water (mL) 1821 6520 4271 +135
Sodium (mg) 3184 5614 5622 +77
Potassium (mg) 4564 4926 5488 +20
Magnesium (mg) 672 667 721 +7
Zinc (mg) 13.9 36.9 32.9 +137
Vitamin C (mg) 161 1009 778 +383
Number of GIS reported 2 3 9 +350
GIS frequency 6 10 27 +350
GIS severity (mm) 100 85 370 +270
Mean GIS Index (a.u.) 35 20 127 +263
GIS, gastrointestinal symptoms. GIS index based on mean data for
frequency × severity for each reported symptom. ∗% change represents
end-point (day 25) relative to pre-challenge.
marathon (15%, Ross et al., 2008), and single-stage ultra-
marathon (21%, Wuthrich et al., 2015). Importantly, our
study is the first to assess respiratory muscle function in
response to ultra-endurance stage-racing. The pre- to post-
challenge reduction in MEP is suggestive of exercise-induced
expiratory muscle fatigue. Given that such fatigue typically
recovers within a few hours of exercise (Romer and Polkey,
2008), the long-lasting (48 h) reduction in MEP might have
been caused by mechanical changes in the expiratory muscles,
including sarcolemmal disruption, myofibrillar disorganization,
and z-band streaming (Reid et al., 2001). However, there are
several lines of evidence that the observed decrease in MEP
might have been largely independent of fatigue. First, the
decrease in expiratory mouth-pressure occurred in the absence
of any change in the perception of respiratory muscle soreness,
thereby bringing into question the notion of respiratory muscle
damage. Moreover, the aforementioned decrease in IC (and
hence TLC) would be expected to attenuate MEP due to
a decrease in passive recoil of the respiratory system and,
in particular, a decrease in the maximal pressure-generating
capacity of the expiratory muscles resulting from alterations
in length-tension characteristics. Indeed, using published data
(Rahn et al., 1946), the observed reduction in vital capacity
(12%) was predicted to evoke a decrease in MEP of 14%.
Accordingly, our data indicate that a large proportion (up to
70%) of the reduction in MEP was independent of expiratory
muscle fatigue.
Finally, we noted large pre- to post-challenge reductions in
expiratory airflow (i.e., FEV1, −9%; PEF, −28%). While such an
obstructive pattern might have been associated with the URTI
that remained throughout the post-challenge assessment, this
appears unlikely given that airway resistance (Raweff and sRaweff)
had decreased pre- to post-challenge. Airflow during spirometry
is dependent on both airway resistance and the driving pressure
of thoracic muscles (Hayes and Kraman, 2009); as such, a more
likely explanation for the reductions in FEV1 and PEF is a
diminished thoracic driving pressure owing to a failure to start
the maneuver from “true” TLC. Despite marked reductions in
pulmonary and respiratory muscle function, the values tended to
remain within normal limits and, therefore were unlikely to pose
an acute clinical concern.
Cardiovascular Responses
The principal finding from the cardiovascular assessment
was a post-challenge decrease in RMSSD (48%) and an
increase in the LF/HF ratio (70%), relative to baseline. These
findings are in agreement with other reports of autonomic
dysfunction following both endurance and ultra-endurance
exercise (Gratze et al., 2005; Scott et al., 2009). When considered
alongside our observation of a post-challenge decrease in
airway resistance (see section “Respiratory Responses”), our
findings support the notion that there might have been a
withdrawal of parasympathetic control and a subsequent increase
in sympathetic cardiac modulation that persisted for at least
48 h post-challenge (Gratze et al., 2005; Scott et al., 2009).
Although autonomic dysfunction may lead to an abnormal
cardiovascular response and reduced exercise capacity (for
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review, see Fu and Levine, 2013), the phenomenon requires
further study in relation to ultra-endurance exercise.
Baseline right ventricular contractility (TAPSE) far exceeded
the reference value (3.4 vs. 1.6 cm; Koestenberger et al., 2009),
and was likely the result of chronic training-induced adaptations.
Blood pressure and measures of arterial structure and stiffness
(cIMT and PWV) were as expected for the participant’s age. Flow-
mediated dilatation and reactive hyperaemia index (measures
of macro- and microvascular endothelial function, respectively)
were at the lower end of age-predicted values (Yan et al., 2005),
although it is unclear whether these parameters were associated
with endothelial dysfunction, per se, or were the result of conduit
artery structural-remodeling in response to chronic training
(Green et al., 2012). A brachial diameter of 0.44 mm, similar to
that previously reported in trained athletes of a similar age to
the present case (Montero et al., 2014), suggests that the slightly
lower-than-expected flow-mediated dilatation might have been a
result of training-induced remodeling of the brachial artery, but
other factors (e.g., oxidative stress resulting from high training
loads) cannot be discounted. We noted a post-challenge increase
in the E/A ratio, indicating an improvement in diastolic function;
however, values remained within normal limits.
We observed no other meaningful pre- to post-challenge
changes in cardiovascular structure or function; i.e., post-
challenge values tended to remain within normal limits. This
is contrary to earlier reports of transient right ventricular
dysfunction and reduced large artery compliance after endurance
exercise (La Gerche et al., 2012) and ultra-endurance exercise
(Bonsignore et al., 2017), respectively. In general, the existing
literature pertaining to acute and/or chronic changes in vascular
structure and function in endurance athletes report equivocal
findings (Vlachopoulos et al., 2010; Green et al., 2012; Burr
et al., 2014; Radtke et al., 2014). The discrepancies among studies
are likely due to methodological differences such as the timing
of post-exercise measurements and the broad range of exercise
intensities and durations. Indeed, while the current challenge was
extreme in scope (i.e., cumulative exercise time, distance, and
ascent), the daily exercise duration and intensity may not have
induced the cardiovascular strain necessary to influence vessel
structure and function.
Nutritional and GI Responses
As expected, energy consumption increased progressively during
the challenge when expressed relative to habitual intake.
In line with the present findings, previous studies report
that completion of ultra-endurance events is associated with
caloric and carbohydrate-rich eating regimens as well as
high sodium and fluid intakes (Glace B.W. et al., 2002;
Paulin et al., 2015). Nevertheless, sudden caloric “overload”
(e.g., ingestion of hyperosmolar solutions) and changes in
food quality (notably fat) during multi-day events can alter
microbiota diversity and GI absorptive characteristics, leading
to increased GIS (e.g., discomfort, sense of fullness, and
urgency to defecate) (Glace B. et al., 2002; de Oliveira and
Burini, 2014). In the present case, energy intake was congruent
with worsening GIS from the mid-point onward, but this
did not appear to critically impede performance. Broader
research indicates that prior exercise training may offer a
degree of “tolerance” to such symptoms, likely due to both
behavioral mechanisms (i.e., greater experience and practice
with individualized nutrition regimens) and physiological
mechanisms (i.e., stronger immunity to endotoxins in more
highly trained runners) (Brock-Utne et al., 1988).
In cohort studies, exercise-induced GI hypoperfusion has been
shown to increase phosphorylation enzyme activity, provoking
transient disruption of tight junction proteins (van Wijck et al.,
2011; Zuhl et al., 2014). Enhanced luminal paracellular transport
and/or ischaemia-associated mucosal damage may increase the
prevalence of systemic lipopolysaccharides (LPS) and symptoms
associated with endotoxaemia. Although acute high-intensity
exercise is associated with increased luminal permeability
(Pals et al., 1997), less is known about prolonged, repetitive,
and low-intensity ultra-endurance exercise. In this case-
study, the participant exhibited mild-to-moderate endotoxaemia
(endotoxin concentrations reaching 25.5 pg·ml−1). Previous
studies in trained endurance athletes have reported mild (5–
15 pg·ml−1; Jeukendrup et al., 2000) to high (>100 pg·ml−1;
Brock-Utne et al., 1988) endotoxin concentrations. Collectively,
these findings are indicative of variable, event-specific and/or
individual endotoxaemic responses.
Elevated endotoxin concentrations have been associated with
low-grade cytokinemia (e.g., IL-6, C-reactive protein), possibly
leading to immunosuppression, and increased prevalence of
URTI (for review, see Mach and Fuster-Botella, 2017). It is
possible, therefore, that endotoxaemia in our participant was
related to the URTI that manifested at day 14 and remained
until the post-challenge assessments. Indeed, athletes are more
prone to URTI because of the physiological stress of exercise
combined with an imbalanced diet, sleep disturbance, and
exposure to environmental extremes (Thomas and Ockhuizen,
2012), all of which manifested in the present challenge. While
recognizing the methodological limitations of endotoxin unit
quantification, the present data indicate that GI responses to
ultra-endurance exercise are transient and demonstrate the
remarkable adaptive nature of the GI-tract to prolonged, multi-
day exercise (Gisolfi, 2000).
In conclusion, this case-report provides novel data on the
integrative physiological response of a trained athlete to a 25-
day ultra-endurance exercise challenge. Relative to baseline,
the participant exhibited marked post-challenge reductions in
pulmonary function, and a decrease in maximum expiratory
pressure that was only moderately attributable to expiratory
muscle fatigue. Although the post-challenge pulmonary function
remained above the lower-limits of normal, the same response
in an individual with a pre-existing respiratory disorder (e.g.,
asthma) may be clinically meaningful. There was evidence of
autonomic dysfunction which might influence the cardiovascular
response and impact on exercise capacity. Finally, there was
mild-to-moderate endotoxaemia, progressive GI distress, and
symptoms of URTI likely related to immunosuppression. Our
data underscore the importance of robust baseline physiological
function prior to participation in such a challenge. More research
is needed to elucidate the implications of chronic participation in
ultra-endurance exercise for physiological function.
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